Dynamic MR lymphangiography and carbon dye for sentinel lymph node detection: A solution for sentinel lymph node biopsy in mucosal head and neck cancer

Head and Neck

Volumn 27, Issue 4, 2005, Pages 333-338

  Nason, Richard W ^a   Torchia, Mark G ^a   Morales, Carmen M ^a   Thliveris, James ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Head and neck cancer; Lymphoscintigraphy; Sentinel node

Indexed keywords

CARBON; GADOMER 17; ISOSULFAN BLUE;

ANATOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; INTRAOPERATIVE PERIOD; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHANGIOGRAPHY; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE; SQUAMOUS CELL CARCINOMA; STAINING; SWINE; TIME; TONGUE;

ANIMALS; CARBON; CARCINOMA, SQUAMOUS CELL; COLORING AGENTS; GADOLINIUM; HEAD AND NECK NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; MAGNETIC RESONANCE IMAGING; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; STIFLE; SWINE; TIME FACTORS; TONGUE;

EID: 15744394568     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20173     Document Type: Article

References (28)

1. Koch WM, Choti MA, Civelek C, Eisele DW, Saunders JR. Gamma probe-directed biopsy of the sentinel node in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1998;124:455-459.
2. Pitman KT, Johnson JT, Edington H, et al. Lymphatic mapping with isosulfan blue dye in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:790-793.
3. Alex JC, Sasaki CT, Krag DN, Wenig B, Pyle PB. Sentinel lymph node radiolocalization in head and neck squamous cell carcinoma. Laryngoscope 2000;110:198-203.
4. Chiesa F, Mauri S, Grana C, et al. Is there a role for sentinel node biopsy in early N0 tongue tumors? Surgery 2000;128:16-21.
5. Zitsch RP III, Todd DW, Renner GJ, Singh A. Intraoperative radiolymphoscintigraphy for detection of occult nodal metastasis in patients with head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2000; 122:662-666.
6. Taylor RJ, Wahl RL, Sharma PK, et al. Sentinel node localization in oral cavity and oropharynx squamous cell cancer. Arch Otolaryngol Head Neck Surg 2001;127: 970-974.
7. Werner JA, Dünne A-A, Ramaswamy A, et al. Number and location of radiolaheled, intraoperatively identified sentinel nodes in 48 head and neck cancer patients with clinically staged N0 and N1 neck. Eur Arch Otorhinolaryngol 2002;259:91-96.
8. Pitman KT, Johnson JT, Brown NL, Myers EN. Sentinel lymph node biopsy in head and neck squamous cell carcinoma. Laryngoscope 2002;112:2101-2113.
9. Mozzillo N, Chiesa F, Botti G, et al. Sentinel node biopsy in head and neck cancer. Ann Surg Oncol 2001;8(9S): 103-105.
10. Shoaib T, Soutar DS, MacDonald DG, et al. The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck. Am Cancer Soc 2001;2077-2083.
11. Ross G, Shoaib T, Soutar DS, et al. The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer. Arch Otolaryngol Head Neck Surg 2002; 128:1287-1291.
12. Stoeckli SJ, Pfaltz M, Steinert H, Schmid S. Histopathological features of occult metastasis detected by sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma. Laryngoscope 2002;112:111-115.
13. Civantos FJ, Gomez C, Duque C, et al. Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry. Head Neck 2003;25:1-9.
14. Asthana S, Suryanarayana Deo SV, Shukla NK, Jain P, Anand M, Kumar R. Intraoperative neck staging using sentinel node biopsy and imprint cytology in oral cancer. Head Neck 2003;25:368-372.
15. Krag DN. Minimal access surgery for staging regional lymph nodes: the sentinel-node concept. Curr Probl Surg 1998;35:955-1017.
16. Zervos EE, Burak WE Jr. Lymphatic mapping in solid neoplasms: state of the art. Cancer Control 2002;9:189-202.
17. Horika L, Weissleder R, Poss K, Papisov MI. Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies. Radiology 1996;198:365-370.
18. Misselwitz B, Platzek J, Weinmann HJ. MR lymphography after interstitial injection of contrast media. Lymphology 1998;31(Suppl):326-329.
19. Torchia MG, Nason R, Danzinger R, Lewis JM, Thliveris JA. Interstitial MR lymphangiography for the detection of sentinel lymph nodes. J Surg Oncol 2001;78:151-157.
20. Torchia MG, Misselwitz B. Combined MR lymphangiography and MR imaging-guided needle localization of sentinel lymph nodes using Gadomer-17. Am J Roentgenol 2002;179:1561-1565.
21. Fennerty MB, Sampliner RE, Hixson LJ, Garewal HS. Effectiveness of India ink as a long-term colonic mucosal marker. Am J Gastroenterol 1992;87:79-81.
22. Takahashi T, Sawai K, Hagiwara A, Takahashi S, Seiki K, Tokuda H. Type-oriented therapy for gastric cancer effective for lymph node metastasis: management of lymph node metastasis using activated carbon particles adsorbing an anticancer agent. Semin Surg Oncol 1991;7: 378-383.
23. Haigh PI, Lucci A, Turner RR, et al. Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma. Cancer 2001;92:535-541.
24. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol 2001;8: 192-197.
25. Lucci A, Turner RR, Morton DL. Carbon dye as an adjunct to isosulfan blue dye for sentinel lymph node dissection. Surgery 1999;126:48-53.
26. Byers RM, Weber RS, Andrews W, McGill D, Kare R, Wolf P. Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. Head Neck 1997;19:14-19.
27. Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med 1998;39:1185-1190.
28. Tafra L, Chua A, Ng P, Aycock D, Swanson M, Lannin D. Filtered versus unfiltered technetium sulfur colloid in lymphatic mapping: a significant variable in a pig model. Ann Surg Oncol 1999;6:83-87.